Carregant...
Anti-rheumatic drugs
Prescription of anti-rheumatic drugs should be by approved name because in most cases differences in absorption can be compensated by titration of dosage against effectiveness and toxicity. There are a few instances, for example phenylbutazone, where known differences of bio-availability justify the...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
1974
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2495494/ https://ncbi.nlm.nih.gov/pubmed/4549519 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|